Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, 2-Cohort Study to Describe the Safety and Efficacy of Ceftaroline Fosamil in Subjects With Staphylococcus Aureus Bacteremia or With Persistent Methicillin-Resistant Staphylococcus Aureus Bacteremia

NCT01701219 is registered in ClinicalTrials.gov with Forest Laboratories as lead sponsor.

NCT NCT01701219
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01701219 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, 2-Cohort Study to Describe the Safety and Efficacy of Ceftaroline Fosamil in Subjects With Staphylococcus Aureus Bacteremia or With Persistent Methicillin-Resistant Staphylococcus Aureus Bacteremia
Lead sponsor
Forest Laboratories
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2013
Completion date
July 31, 2014
Enrollment
56 (actual)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

methicillin-resistant staphylococcus aureus (mrsa) bacteremia, staphylococcus aureus bacteremia